Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacodynamics of opioids: recent developments

G Folkers1, M Michael

  • 1Department of Pharmacy, ETH Zürich, Switzerland.

Pharmaceutica Acta Helvetiae
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CIDP With and Without Monoclonal Gammopathy of Undetermined Significance (MGUS): Comparison of Clinical Phenotype, Diagnostic Features, and Treatment Response.

Journal of the peripheral nervous system : JPNS·2026
Same author

Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, multicentre, real-world analysis.

ESMO real world data and digital oncology·2026
Same author

Integrating behavioral assessment in instructional design for competency-based medical education.

Frontiers in medicine·2024
Same author

Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: Based on site, grade, and region.

Asia-Pacific journal of clinical oncology·2021
Same author

An Experimental Study on the Rheological Behavior of Carbon Black-Boron Nitride Hybrid Nanofluids and Development of a New Correlation.

Journal of nanoscience and nanotechnology·2021
Same author

Immune Checkpoint Blockade in Lower Gastrointestinal Cancers: A Systematic Review.

Annals of surgical oncology·2021

Understanding opioid drug action requires examining ligand-receptor interactions at a molecular level. Research is advancing our knowledge of how these drugs mimic natural compounds, leading to new pharmacological tools.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Drug pharmacodynamics involve receptor interactions and signal transduction.
  • Understanding opioid and opioid-like drugs necessitates a molecular definition of ligand-target protein interactions.
  • Characterizing both ligands and receptor proteins is crucial for a rational drug action approach.

Purpose of the Study:

  • To review the progress in understanding the molecular mechanisms of opioid drug action.
  • To highlight the importance of molecular characterization in opioid pharmacology.
  • To discuss the development of new molecular tools based on this understanding.

Main Methods:

  • Literature review of current research in opioid pharmacology.
  • Analysis of molecular interactions between ligands and receptor proteins.

Related Experiment Videos

  • Discussion of peptidomimetics and their role in mimicking natural ligands.

    • Main Results:

    • Significant advancements have been made in understanding ligand-receptor interactions for opioids.
    • Molecular insights are beginning to reveal what peptidomimetics like morphine mimic.
    • New molecular tools have emerged from this enhanced understanding.

    Conclusions:

    • A molecular approach to ligand-receptor interactions is key to understanding opioid pharmacodynamics.
    • Continued research into molecular mechanisms will drive the development of novel opioid-based therapeutics.
    • The field is progressing towards a comprehensive understanding of opioid and opioid-like drug actions.